Aurobindo Pharma Limited — Clindamycin Exporter Profile
Indian Pharmaceutical Exporter · #4 for Clindamycin · $12.6M export value · DGFT Verified
Aurobindo Pharma Limited is the #4 Indian exporter of Clindamycin with $12.6M in export value and 63 verified shipments. Aurobindo Pharma Limited holds a 10.4% market share in Clindamycin exports across 2 countries. The company exports 81 pharmaceutical products worth $1.1B across 18 therapeutic categories.
Aurobindo Pharma Limited — Clindamycin Export Profile: Buyers & Destinations
Where Does Aurobindo Pharma Limited Export Clindamycin?
| Country | Value | Shipments | Share |
|---|---|---|---|
| UNITED STATES | $7.5M | 187 | 81.2% |
| CANADA | $1.7M | 62 | 18.1% |
| UNITED STATES OF AMERICA | $59.1K | 2 | 0.6% |
Aurobindo Pharma Limited exports Clindamycin to 3 countries. The largest destination is UNITED STATES accounting for 81.2% of Aurobindo Pharma Limited's Clindamycin shipments, followed by CANADA (18.1%) and UNITED STATES OF AMERICA (0.6%). These destinations reflect Aurobindo Pharma Limited's established distribution network and regulatory approvals in key markets.
Who Are the Top Buyers of Clindamycin from Aurobindo Pharma Limited?
| Buyer | Country | Value | Orders |
|---|---|---|---|
| AUROLOGISTICS LLC (AUROBINDO PHARMA | UNITED STATES | $2.2M | 56 |
| AUROLOGISTICS LLC AUROBINDO PHARM | UNITED STATES | $1.6M | 36 |
| AUROLOGISTICS LLC, (AUROBINDO PHARM | UNITED STATES | $1.0M | 22 |
| NORTHSTAR DISTRIBUTION CENTER 8912 | UNITED STATES | $981.0K | 31 |
| AURO PHARMA INC | CANADA | $969.2K | 37 |
| AUROLOGISTICS LLC | UNITED STATES | $705.8K | 16 |
| AURO PHARMA INC, | CANADA | $459.3K | 15 |
| AUROLOGISTICS LLC, | UNITED STATES | $257.3K | 7 |
| AUROLOGISTICS LLC(AUROBINDO PHARMA | UNITED STATES | $124.9K | 3 |
| NORTHSTAR DISTRIBUTION CENTER | UNITED STATES | $111.5K | 3 |
Aurobindo Pharma Limited supplies Clindamycin to 22 buyers globally. The largest buyer is AUROLOGISTICS LLC (AUROBINDO PHARMA (UNITED STATES), followed by AUROLOGISTICS LLC AUROBINDO PHARM (UNITED STATES) and AUROLOGISTICS LLC, (AUROBINDO PHARM (UNITED STATES). These buyers represent pharmaceutical distributors, hospital groups, and government procurement agencies in their respective markets.
What Is India's Total Clindamycin Export Value and How Much Does Aurobindo Pharma Limited Contribute?
India exported $47.6M worth of Clindamycin through 7,242 shipments from 527 suppliers to 144 countries, serving 1,029 buyers globally. Aurobindo Pharma Limited contributes $12.6M to this total, accounting for 10.4% of India's Clindamycin exports. Aurobindo Pharma Limited ships Clindamycin to 3 countries through 22 buyers.
What Is the Average Shipment Value for Aurobindo Pharma Limited's Clindamycin Exports?
Aurobindo Pharma Limited's average Clindamycin shipment value is $199.2K per consignment, based on 63 shipments totaling $12.6M. The largest destination is UNITED STATES (81.2% of Aurobindo Pharma Limited's Clindamycin exports).
How Does Aurobindo Pharma Limited Compare to Other Indian Clindamycin Exporters?
Aurobindo Pharma Limited ranks #4 among 527 Indian Clindamycin exporters with a 10.4% market share. The top 3 exporters are ENCUBE ETHICALS PRIVATE LIMITED ($14.6M), AUROBINDO PHARMA LTD ($9.4M), GLENMARK PHARMACEUTICALS LIMITED ($4.7M). Aurobindo Pharma Limited processed 63 shipments to 2 destination countries.
What Clindamycin Formulations Does Aurobindo Pharma Limited Export?
| Product Description / Formulation | Value | Shipments |
|---|---|---|
| CLINDAMYCIN HYDROCHLORIDE CAPSULES 300MG | $1.3M | 27 |
| CLINDAMYCIN HYDROCHLORIDE CAPSULES 150MG | $571.9K | 13 |
| CLINDAMYCIN PALMITATE HYDROCHLORIDE FOR | $571.3K | 17 |
| CLINDAMYCIN PALMITATE HYDROCHLORIDE ORAL | $542.8K | 13 |
| CLINDAMYCIN HYDROCHLORIDE CAPSULES 300MG(CLINDAMYCIN HYDROCHLORIDE CAPSULES USP300 MG) 100'S | $498.2K | 10 |
| CLINDAMYCIN HYDROCHLORIDE CAPSULES 300MG(CLINDAMYCIN HYDROCHLORIDE CAPSULES USP300 MG) 100'SNOS | $469.4K | 12 |
| CLINDAMYCIN PALMITATE HYDROCLORIDE FOR ORAL SOLUTION 75MG/5ML 1'S(CLINDAMYCIN PALMITATE HYDROCHLORIDE FOR ORAL SOLUTION | $206.2K | 7 |
| CLINDAMYCIN HYDROCHLORIDE CAPSULES USP 3 | $200.0K | 4 |
| CLINDAMYCIN HYDROCHLORIDE CAPSULES 300MGCLINDAMYCIN HYDROCHLORIDE CAPSULES USP300 MG 100'S | $200.0K | 4 |
| CLINDAMYCIN PALMITATE HYDROCHLORIDE FORORAL SOLUTION USP 75MG/5ML, 100ML PACK | $190.9K | 7 |
Aurobindo Pharma Limited exports 91 distinct Clindamycin formulations including tablets, capsules, syrups, and combination drugs. The top formulation is CLINDAMYCIN HYDROCHLORIDE CAPSULES 300MG with 27 shipments worth $1.3M.
Regulatory Requirements: Exporting Clindamycin to Key Markets
What Aurobindo Pharma Limited must comply with to export Clindamycin to its top destination countries
United States — FDA
Approval Process
ANDA (Abbreviated New Drug Application) for generics. Indian manufacturing site must pass FDA pre-approval inspection. Drug Master File (DMF) required for APIs.
Timeline: 10–18 months for ANDA approval
GMP & Export Requirements
FDA cGMP compliance (21 CFR 210/211); facility inspection by FDA
Drug Listing with FDA; Export Certificate from CDSCO India; Import Alert screening via FDA PREDICT system
Note: Subject to FDA Import Alerts. Open Form 483 observations can block all exports from a facility.
Canada — HC
Approval Process
ANDS (Abbreviated New Drug Submission) referencing Canadian Reference Product. Comparative bioavailability study required.
Timeline: 12–18 months
GMP & Export Requirements
Health Canada GMP (GUI-0001); Drug Establishment Licence (DEL) inspection
Drug Identification Number (DIN) for each product; Certificate of Pharmaceutical Product from CDSCO
Note: Subject to Good Import Practices and annual C.01.014.6 review.
Regulatory information is provided for general reference based on publicly available guidelines. Requirements vary by formulation, dosage form, and therapeutic classification. Exporters should consult qualified regulatory affairs professionals for case-specific guidance.
How Does Aurobindo Pharma Limited Compare to Nearest Clindamycin Exporters?
Exporters ranked immediately above and below #4 by export value
| # | Supplier | Export Value | Shipments | Countries | Avg/Shipment |
|---|---|---|---|---|---|
| 5 | GLENMARK PHARMACEUTICALS LIMITED | $4.7M | 199 | 6 | $23.6K |
| 3 | MICRO LABS LIMITED | $4.7M | 93 | 4 | $50.0K |
| 4 | AUROBINDO PHARMA LIMITED ★ | $3.1M | 63 | 2 | $50.0K |
| 6 | BIOMATRIX HEALTHCARE PRIVATE LIMITED | $3.1M | 62 | 6 | $50.0K |
| 10 | ZYDUS LIFESCIENCES LIMITED | $2.3M | 71 | 1 | $33.0K |
Aurobindo Pharma Limited ranks #4 among 527 Indian Clindamycin exporters. Average shipment value of $50.0K compared to the market average of $90.3K. The closest competitors by value are GLENMARK PHARMACEUTICALS LIMITED and MICRO LABS LIMITED.
Which Indian Ports Ship Clindamycin Exports?
| Port | Shipments | % Share |
|---|---|---|
| DELHI AIR CARGO ACC (INDEL4) | 1,184 | 16.3% |
| SAHAR AIR | 1,119 | 15.5% |
| SAHAR AIR CARGO ACC (INBOM4) | 966 | 13.3% |
| DELHI AIR | 674 | 9.3% |
| NHAVA SHEVA SEA (INNSA1) | 437 | 6.0% |
| JNPT/ NHAVA SHEVA SEA | 328 | 4.5% |
| Bombay Air | 309 | 4.3% |
| Delhi Air | 201 | 2.8% |
What Other Antibiotics Products Does Aurobindo Pharma Limited Export?
Aurobindo Pharma Limited also exports these antibiotics products. Each links to the detailed product page.
About Aurobindo Pharma Limited
Aurobindo Pharma Limited exports 81 products worth $1.1B. Beyond Clindamycin, top products include Amoxicillin, Potassium, Pantoprazole, Clopidogrel, Rosuvastatin. View the complete Aurobindo Pharma Limited profile for full portfolio analysis.
Market Intelligence
Latest developments and market context
Detailed market intelligence for Clindamycin — including regulatory updates, trade policy changes, and competitive landscape analysis — will be available in an upcoming update. This section will feature AI-researched insights from verified industry sources, government notifications, and market reports.
Official References & Regulatory Resources
- CDSCO India
- Pharmexcil
- IBEF — India Pharma Industry
- Ministry of Commerce — Pharma Exports
- India Trade Statistics (DGFT)
Verify manufacturer licensing and export certifications with the official agencies above.
Research Methodology & Data Transparency
Suresh Sormare
Verified AuthorPharmaceutical Export-Import Analyst & Trade Intelligence Expert
Suresh Sormare is a pharmaceutical export-import analyst with deep expertise in Indian Customs (DGFT) data, HS code classification, and global pharmaceutical supply chains. His analysis covers 10M+ shipment records across 150+ countries and is used by manufacturers, procurement agencies, and trade consultants worldwide. Suresh specializes in identifying verified suppliers and buyers from customs records, mapping bilateral pharmaceutical trade corridors, analyzing tariff structures and regulatory frameworks across 170+ destination markets, and benchmarking competitive positioning for finished pharmaceutical formulations. His methodology combines granular customs transaction data with regulatory intelligence from FDA, EMA, WHO, CDSCO, and 40+ national drug authorities to deliver actionable trade insights for the pharmaceutical formulations sector.
linkedin.com/in/sureshsormarePrimary Data Source
All trade data is sourced from Indian Customs (DGFT) official shipping bill records — the authoritative government database for India's pharmaceutical trade. Each verified record contains exporter name, consignee (buyer) name, detailed product description, quantity, declared FOB value (USD), port of loading, destination country, and shipment date.
Analysis Methodology
- 1.Product Matching: Clindamycin shipments identified using fuzzy matching on DGFT product description fields, validated against Indian Pharmacopoeia nomenclature.
- 2.Supplier Identification: Aurobindo Pharma Limited matched across shipments using name normalization, accounting for company name formatting variations.
- 3.Statistical Normalization: Shipment values are statistically normalized to ensure accurate market share representation. This removes the impact of unusually large one-off transactions that could distort company rankings.
- 4.Verified Records: This page is backed by 251 individual customs records matching Aurobindo Pharma Limited exporting Clindamycin, covering 91 formulations to 3 countries via 22 buyers.
Government-Sourced Data
Official DGFT customs records
Transparent Methodology
Calculations fully disclosed above
Global Coverage
Exports to 144+ countries, 1,029+ buyers
Expert-Reviewed
Analyzed by pharmaceutical trade specialists
Get Clindamycin Export Data from Aurobindo Pharma Limited
Access shipment-level details, pricing data, buyer connections, and competitive analysis for Aurobindo Pharma Limited's Clindamycin exports. TransData Nexus provides verified Indian Customs (DGFT) data trusted by pharmaceutical trade professionals worldwide.
Aurobindo Pharma Limited
Full Company Profile →
81 products · $1.1B total trade · 18 categories
Clindamycin Stats
Company Overview
Top Products by Aurobindo Pharma Limited
Related Analysis
Need Detailed Export Data?
Access shipment-level records, pricing trends, and buyer contacts for Aurobindo Pharma Limited.
Request DemoView Pricing →Data Source
Trade data sourced from Indian Customs (DGFT) export shipment records. Values represent FOB export value in USD. Market share calculated relative to total Indian pharmaceutical exports for Clindamycin. For current shipment-level data, contact TransData Nexus.